Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole Plus Cabazitaxel or Docetaxel in Castration-Resistant Prostate Cancer
NCT04337580Phase 2Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2021
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omeprazole in prostate cancer (PCa), sponsored by Wake Forest University Health Sciences. Started Mar 2021; status: recruiting.
02
Drugs
omeprazole
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04337580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04337580.